Duchenne muscular dystrophy and dystrophin: pathogenesis and opportunities for treatment.
Duchenne muscular dystrophy (DMD) is caused by mutations in the gene that encodes the 427-kDa cytoskeletal protein dystrophin. Increased knowledge of the function of dystrophin and its role in muscle has led to a greater understanding of the pathogenesis of DMD. This, together with advances in the g...
Main Authors: | Nowak, K, Davies, K |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2004
|
Títulos similares
-
Dystrophin hydrophobic regions in the pathogenesis of Duchenne and Becker muscular dystrophies
por: Yingyin Liang, et al.
Publicado: (2015-05-01) -
The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
por: Guiraud, S, et al.
Publicado: (2019) -
Micro-dystrophin genes bring hope of an effective therapy for duchenne muscular dystrophy
por: Davies, K, et al.
Publicado: (2019) -
Therapeutic Strategies for Dystrophin Replacement in Duchenne Muscular Dystrophy
por: Cedric Happi Mbakam, et al.
Publicado: (2022-03-01) -
Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
por: Griffin, J, et al.
Publicado: (2002)